[1] 中国抗癌协会. 肝门部胆管癌规范化诊治专家共识(2015). 中华肝胆外科杂志,2015,21:505-511.
[2] 陈亚进,商昌珍. 肝内胆管细胞癌诊治策略. 中国实用外科杂志,2015,35: 43-45.
[3] 梁廷波,白雪莉. 肝门部胆管癌多学科团队的诊断与治疗. 中华消化外科杂志,2015,14:268-274.
[4] 沈锋,王葵,阎振林,等. 1370例肝内胆管细胞癌肝切除术的疗效及预后因素分析. 中华消化外科杂志,2016,15:319-328.
[5] 黄龙,严茂林,魏少明,等. 肝内胆管黏液腺癌与肝内胆管细胞癌的临床病理特征及预后分析. 中华消化外科杂志,2016,15:335-338.
[6] Ting CF,Huang WH,Feng CL,et al. Clinical factors associated with the survival of patients with intrahepatic cholangiocarcinoma. AIDM,2015,3:11-17.
[7] 闫加艳,陈炜,王坚. 顺逆结合肝门显露法治疗侵犯肝门的肝内胆管细胞癌. 中华消化外科杂志,2017,16: 417-422.
[8] Fukami Y,Kaneoka Y,Maeda A,et al. Major hepatopan-creatoduodenectomy with simultaneous resection of the hepatic artery for advanced biliary cancer. Langenbecks Arch Surg,2016,401: 471-478.
[9] 林杰,刘付宝. 肝门部胆管癌手术治疗中血管(特别是肝动脉)切除重建的意义. 肝胆外科杂志,2016,24: 369.
[10] 何宇,王曙光,别平. 肝门部胆管癌根治联合血管切除重建的难点与技巧. 中华普外科手术学杂志(电子版),2015,9: 16-19. |
